Atossa Therapeutics Inc (NASDAQ:ATOS)

0.6948
Delayed Data
As of Mar 24
 +0.0155 / +2.28%
Today’s Change
0.50
Today|||52-Week Range
1.54
+31.47%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Atossa Therapeutics Inc have a median target of 4.00, with a high estimate of 4.00 and a low estimate of 4.00. The median estimate represents a +475.71% increase from the last price of 0.69.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Atossa Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.06
Sales
$0.00
Reporting Date
May 16

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 0.00%
 
 
 
 
 
 
Growthannually -14.29%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.